None
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Subject whose age of 20 years or more and less than 55 years at informed consent 2) Subject whose BMI is 25 kg/m2 or more and less than 30 kg/m2 3) Subject who weighs less than 88 kg 4) Subject having a briefing of the content of the present study, fully understanding and agreeing to its objective and being able to personally sign a written informed consent
Exclusion criteria
Exclusion criteria: 1) Subject who has a mental disease such as depression, schizophrenia, epilepsy or bulimia nervosa 2) Subject who has allergic disease, cardiovascular, respiratory, thyroid gland malfunction, diabetes, heart disease, brain disease, gout or sleep disorder 3) Subject who takes regularly medicinal drugs or pharmaceuticals having an effect on the weight 4) Subject who has the possibility of developing allergic symptoms by the test food (noni allergy) 5) Subject who has a snacking habit 6) Female subject who is pregnant or may be pregnant 7) Female subject who is in lactating 8) Subject who has blood sample of 200 ml or more within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood) 9) Subject who participated in other clinical trials within the past 4 months or currently participates in other clinical trials or plans to participate in other clinical trials during the examination period 10) Subject deemed unsuitable by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body weight, BMI | — |
Secondary
| Measure | Time frame |
|---|---|
| Waist circumference, Visceral fat area, Total fat percentage, Total fat area | — |
Countries
Japan
Contacts
Soiken Inc. R&D Division